HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection afforded by sickle-cell trait (Hb AS): what happens when malarial selection pressures are alleviated?

Abstract
A study of reproductive outcome in Mobile, AL was conducted among a large maternal cohort with sickle-cell disease (Hb SS), sickle-cell trait (Hb AS), and no hemoglobinopathies (Hb AA). It was found that mean gravidity and live births among Hb AS women were significantly higher than among Hb AA women. These findings were surprising since it is generally held that once malarial pressure is alleviated, any reproductive advantage that might be conferred by Hb AS would disappear and fertility levels would reach levels similar to or slightly less than that of Hb AA women. A search of the literature was subsequently conducted and a large cohort study of an African-derived population was found in the United Kingdom. Results from this study also showed that parity was significantly higher among Hb AS women compared to Hb AA women. If survivorship is similar among Hb AS and Hb SS women, findings from these two studies raise doubts whether directional selection is occurring against the Rb S allele in nonmalarial environments. Balancing selection may still be occurring.
AuthorsC Hoff, I Thorneycroft, F Wilson, M Williams-Murphy
JournalHuman biology (Hum Biol) Vol. 73 Issue 4 Pg. 583-6 (Aug 2001) ISSN: 0018-7143 [Print] United States
PMID11512684 (Publication Type: Comparative Study, Journal Article)
Topics
  • Africa (ethnology)
  • Alabama (epidemiology)
  • Anemia, Sickle Cell (complications, ethnology, genetics)
  • Black People (genetics)
  • Case-Control Studies
  • Female
  • Gene Frequency (genetics)
  • Heterozygote
  • Humans
  • Linear Models
  • Malaria (complications, genetics)
  • Parity
  • Pregnancy
  • Pregnancy Complications, Hematologic (ethnology)
  • Pregnancy Outcome (epidemiology)
  • Retrospective Studies
  • Selection, Genetic
  • Sickle Cell Trait (complications, ethnology, genetics)
  • United Kingdom (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: